Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• DNA topoisomerase IIalpha (topo IIalpha) is crucial for managing DNA topology during cellular processes.
• Melphalan is a chemotherapeutic agent that induces DNA damage, primarily cross-links.
• The precise role of topo IIalpha in processing melphalan-induced DNA damage and cytotoxicity is not fully understood.

Purpose of the Study:

• To investigate the consequences of interfering with topo IIalpha activity on melphalan-induced cytotoxicity.
• To elucidate the mechanisms by which topo IIalpha influences melphalan's DNA damage processing and repair.
• To explore the potential of modulating topo IIalpha activity to enhance melphalan efficacy in chemotherapy.

Main Methods:

• Utilized V79 Chinese hamster lung fibroblast mutant cell lines with dysfunctional topo IIalpha.
• Treated cells with etoposide (VP-16) and merbarone/ICRF-187 to inhibit topo IIalpha activity.
• Assessed cytotoxicity using clonogenic survival assays and DNA damage using alkaline elution and sister chromatid exchange (SCE) assays.

Main Results:

• All three methods of interfering with topo IIalpha significantly potentiated melphalan-induced cytotoxicity.
• Melphalan-induced DNA cross-link formation and repair were faster in topo IIalpha-deficient cells (V511) but resulted in higher SCE.
• A strong correlation was observed between increased melphalan-induced SCE and enhanced cytotoxicity.

Conclusions:

• Topo IIalpha plays a critical role in the processing of melphalan-induced DNA damage, with deficiency leading to increased sensitivity.
• In the absence of functional topo IIalpha, DNA damage is rerouted to recombination repair, potentially causing genetic instability and lethality.
• Downregulating topo IIalpha activity, possibly with agents like VP-16 or ICRF-187, could enhance melphalan's efficacy in combination chemotherapy.